Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 238939, 7 pages
http://dx.doi.org/10.1155/2014/238939
Research Article

Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits

1UNC Eshelman School of Pharmacy and Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, CB No. 7590, Chapel Hill, NC 27599-7590, USA
2Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
3Department of Ophthalmology, School of Medicine, Duke University, Durham, NC 27710, USA
4Health Services Research and Development, Durham VA Medical Center, Durham, NC 27710, USA
5Glaucoma Service and Research Center, UNC Kittner Eye Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
6Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322, USA
7Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA
8Department of Science and Mathematics, Institutional Research, Husson University, Bangor, ME 04401, USA
9Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21209, USA
10Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD 21209, USA

Received 29 December 2013; Revised 4 March 2014; Accepted 6 April 2014; Published 24 April 2014

Academic Editor: David J. Calkins

Copyright © 2014 Betsy Sleath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Glaucoma Research Foundation,” 2005, http://www.glaucoma.org/.
  2. L. Pizzarello, A. Abiose, T. Ffytche et al., “VISION 2020: the right to sight—a global initiative to eliminate avoidable blindness,” Archives of Ophthalmology, vol. 122, no. 4, pp. 615–620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. O. Gordon, J. A. Beiser, J. D. Brandt et al., “The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma,” Archives of Ophthalmology, vol. 120, no. 6, pp. 714–720, 2002. View at Google Scholar · View at Scopus
  4. E. J. Higginbotham, J. S. Schuman, I. Goldberg et al., “One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1286–1293, 2002. View at Google Scholar · View at Scopus
  5. C. B. Camras, A. Alm, P. Watson, and J. Stjernschantz, “Latanoprost, a prostaglandin analog, for glaucoma therapy: efficacy and safety after 1 year of treatment in 198 patients,” Ophthalmology, vol. 103, no. 11, pp. 1916–1924, 1996. View at Google Scholar · View at Scopus
  6. D. S. Friedman, S. R. Hahn, L. Gelb et al., “Doctor-patient communication, health-related beliefs, and adherence in glaucoma. Results from the glaucoma adherence and persistency study,” Ophthalmology, vol. 115, no. 8, pp. 1320–1327.e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Murakami, B. W. Lee, M. Duncan et al., “Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population,” Archives of Ophthalmology, vol. 129, no. 7, pp. 872–878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. W. Herndon, T. M. Brunner, and J. N. Rollins, “The glaucoma research foundation patient survey: patient understanding of glaucoma and its treatment,” American Journal of Ophthalmology, vol. 141, no. 1, pp. S22–S27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sleath, R. H. Rubin, and S. A. Huston, “Hispanic ethnicity, physician-patient communication, and antidepressant adherence,” Comprehensive Psychiatry, vol. 44, no. 3, pp. 198–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sleath, J. A. Tulsky, B. M. Peck, and J. Thorpe, “Provider-patient communication about antidepressants among veterans with mental health conditions,” The American Journal of Geriatric Pharmacotherapy, vol. 5, no. 1, pp. 9–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Sleath, D. M. Carpenter, G. X. Ayala et al., “Provider discussion, education, and question-asking about control medications during pediatric asthma visits,” International Journal of Pediatrics, vol. 2011, Article ID 212160, 7 pages, 2011. View at Publisher · View at Google Scholar
  12. R. L. Street Jr., “Communication in medical encounters: an ecological perspective,” in Handbook of Health Communication, T. L. Thompson, A. Dorsey, K. Miller, and R. Parrott, Eds., pp. 63–89, Lawrence Erlbaum Associates, Mahwah, NJ, USA, 2003. View at Google Scholar
  13. R. L. Street Jr., H. S. Gordon, M. M. Ward, E. Krupat, and R. L. Kravitz, “Patient participation in medical consultations: why some patients are more involved than others,” Medical Care, vol. 43, no. 10, pp. 960–969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. C. Davis, S. W. Long, R. H. Jackson et al., “Rapid estimate of adult literacy in medicine: a shortened screening instrument,” Family Medicine, vol. 25, no. 6, pp. 391–395, 1993. View at Google Scholar · View at Scopus
  15. N. Congdon, B. O'Colmain, C. C. Klaver et al., “Causes and prevalence of visual impairment among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 477–485, 2004. View at Publisher · View at Google Scholar
  16. B. Sleath, S. J. Blalock, D. Covert, A. C. Skinner, K. W. Muir, and A. L. Robin, “Patient race, reported problems in using glaucoma medications, and adherence,” ISRN Ophthalmology, vol. 2012, Article ID 902819, 7 pages, 2012. View at Publisher · View at Google Scholar
  17. B. L. Nordstrom, D. S. Friedman, E. Mozaffari, H. A. Quigley, and A. M. Walker, “Persistence and adherence with topical glaucoma therapy,” American Journal of Ophthalmology, vol. 140, no. 4, pp. 598.e1–598.e11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. G. F. Schwartz, R. Platt, G. Reardon, and M. A. Mychaskiw, “Accounting for restart rates in evaluating persistence with ocular hypotensives,” Ophthalmology, vol. 114, no. 4, pp. 648–652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Friedman, C. O. Okeke, H. D. Jampel et al., “Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma,” Ophthalmology, vol. 116, no. 6, pp. 1097–1105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. C. Schneider, P. D. Cleary, A. M. Zaslavsky, and A. M. Epstein, “Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and whites?” The Journal of the American Medical Association, vol. 286, no. 12, pp. 1455–1460, 2001. View at Google Scholar · View at Scopus
  21. “Chronic disease prevention and health promotion,” Centers for Disease Control and Prevention website, 2012, http://www.cdc.gov/chronicdisease/resources/publications/AAG/chronic.htm.
  22. S. Tavernise, “Whites account for under half of births in U.S. New York Times,” 2012, http://www.nytimes.com/2012/05/17/.
  23. M. H. Lopez, “Latinos and education: explaining the attainment gap,” Pew Research Center Publications website, 2009, http://www.pewhispanic.org/2009/10/07/latinos-and-education-explaining-the-attainment-gap/.
  24. D. Vlahov, K. T. Bond, K. C. Jones, and D. C. Ompad, “Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009-2010 influenza season,” Journal of Community Health, vol. 37, no. 2, pp. 282–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. S. Friedman, S. K. West, B. Munoz et al., “Racial variations in causes of vision loss in nursing homes: the Salisbury Eye Evaluation in Nursing Home Groups (SEEING) study,” Archives of Ophthalmology, vol. 122, no. 7, pp. 1019–1024, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Stein, N. Talwar, A. M. Laverne, B. Nan, and P. R. Lichter, “Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma,” Archives of Ophthalmology, vol. 130, no. 12, pp. 1579–1588, 2012. View at Publisher · View at Google Scholar
  27. D. Price and M. Duerden, “Inhalers: education and training needs,” Current Therapeutics, vol. 43, no. 5, pp. 21–26, 28–29, 2002. View at Google Scholar
  28. G. K. Crompton, P. J. Barnes, M. Broeders et al., “The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team,” Respiratory Medicine, vol. 100, no. 9, pp. 1479–1494, 2006. View at Publisher · View at Google Scholar · View at Scopus